Position in AKBA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$175,851
+$101,478 QoQ
Shares Held
154,256
+466.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 170 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Mariner, LLC holds $80,358,857 across 29 Drug Manufacturers - Specialty & Generic names. AKBA ranks #21 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
155,039 | $26,130,272 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
23,965 | $12,984,955 | |
| 3 | HLN |
Haleon plc
|
771,516 | $7,198,243 | |
| 4 | ZTS |
Zoetis Inc.
|
96,951 | $6,966,897 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
313,725 | $5,430,579 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
308,157 | $4,939,755 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
125,843 | $4,263,560 | |
| 8 | LQDA |
Liquidia Corp
|
43,647 | $3,479,975 |
All Filings in AKBA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,851 | 154,256 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $74,373 | 27,243 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $139,506 | 38,326 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $72,516 | 37,769 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $28,393 | 14,944 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||